E5501

DRUG4 trials

Sponsors

Eisai Inc.

Conditions

Healthy SubjectsIdiopathic Thrombocytopenia PurpuraIdiopathic Thrombocytopenic Purpura (ITP)

Phase 1

Single and Multiple Dose Asian Bridging Study

CompletedNCT01251731

Eisai Inc.Healthy Subjects

Start: 2010-07-31Updated: 2012-04-06

A Single-Center, Open-Label, Randomized, 3-Treatment Crossover Bioavailability Study of Single Oral Doses of E5501 Old Tablet Formulation Under Fasted Conditions and a New Tablet Formulation Under Fed and Fasted Conditions in Healthy Subjects

CompletedNCT01260155

Eisai Inc.Healthy Subjects

Start: 2010-01-31End: 2010-06-30Updated: 2013-11-01

A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects

CompletedNCT01289509

Eisai Inc.Idiopathic Thrombocytopenia Purpura

Start: 2010-12-31End: 2011-05-31Updated: 2013-11-01

Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Verapamil and Cyclosporine.

CompletedNCT01437384

Eisai Inc.Idiopathic Thrombocytopenic Purpura (ITP)

Start: 2011-09-30Updated: 2012-05-21